Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-06-12

Clinical Trial Update: Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I Disorder [Phase 4]

View source ↗

Summary

A Phase 4 trial assessed olanzapine versus placebo for mania in adolescents with Bipolar I disorder; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zyprexa (olanzapine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Bipolar Disorder | Phase 4 | Status: COMPLETED